GoKawiilThe most formidable barrier in medicine is the one that separates the brain from the bloodstream. Some small, simple chemical compounds such as paracetamol can cross the blood–brain barrier, but for larger molecules, such as proteins and messenger RNA, it is completely impermeable. There is a good reason for this — toxins and pathogens swimming in the blood could wreak havoc in the brain. But the barrier also makes it difficult to treat the devastating diseases that affect this delicate organ.
Drug-delivering particles aim to breach the blood–brain barrier
Why This Matters
The blood-brain barrier blocks most large therapeutic molecules like proteins and mRNA from reaching the brain, which is a core reason neurological diseases remain so hard to treat. Efforts to design drug-delivering particles that can cross this barrier could unlock a whole class of treatments that current chemistry cannot deliver.
Key Takeaways
- The blood-brain barrier lets small compounds like paracetamol through but is impermeable to proteins and mRNA.
- That selectivity protects the brain from blood-borne toxins and pathogens, but also blocks treatment.
- Engineered drug-delivering particles are being pursued as a way to get large molecules into the brain.
Get alerts for these topics